Oral Cavity Carcinoma — Trials

Oral Cavity Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

310 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 94
Recruiting: 43
Ph III recruiting: 9
Growth YoY: +13.6%
Industry share: 6%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (38)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05608369	Vorinostat in Combination With Chemoradiation in Locally Advanced HPV Negative HNSCC(HPV)	withdrawn	Phase 2	0	Case Comprehensive Cancer CenterOTHER	1	Apr 4, 2025	clinicaltrials
NCT06084845	Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck Cancer	withdrawn	Phase 2	0	ECOG-ACRIN Cancer Research GroupNETWORK	0	Jul 25, 2024